Box score
TNF Pharmaceuticals, Inc.
Reported $26.9M sold in a new Form D filed May 31, 2024 (New York, New York).
- Biggest raise
- $26.9M filed May 31, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- New York, New York
- Season rank
- #180 of 1,389 in the Bio & Health League; #745 of 12,443 overall (2024)
- Incorporated
- 2023
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-09-05 | New notice | $7M | $7M | SEC |
| 2024-05-31 | New notice | $15.2M | $15.2M | SEC |
| 2024-05-31 | New notice | $26.9M | $26.9M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1321834.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Kolon TissueGene, Inc. | Bio & Health | $35M |
| 2 | Pep2Tango Therapeutics, Inc. rookie | Bio & Health | $16.7M |
| 3 | Senseonics Holdings, Inc. | Bio & Health | $16M |
| 4 | AgNovos Bioscience, Inc. | Bio & Health | $13.4M |
| 5 | AsclepiX Therapeutics, Inc. | Bio & Health | $10M |
| 6 | CoapTech, Inc. | Bio & Health | $7.1M |